The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 09, 2021

Filed:

Sep. 09, 2016
Applicants:

Tarjei Mikkelsen, Cambridge, MA (US);

Benjamin Levine Ebert, Boston, MA (US);

Quinlan Sievers, Boston, MA (US);

The Broad Institute, Inc., Cambridge, MA (US);

President and Fellows of Harvard College, Cambridge, MA (US);

The Brigham and Women's Hospital, Inc., Boston, MA (US);

Inventors:

Tarjei Mikkelsen, Cambridge, MA (US);

Benjamin Levine Ebert, Boston, MA (US);

Quinlan Sievers, Boston, MA (US);

Assignees:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/02 (2006.01); C12Q 1/68 (2018.01); G01N 33/68 (2006.01); C07K 14/47 (2006.01); C12N 5/00 (2006.01); C12Q 1/6883 (2018.01); C07K 19/00 (2006.01); C12N 15/62 (2006.01); C12N 5/0781 (2010.01); C12N 5/09 (2010.01); C12N 5/07 (2010.01); C12Q 1/6886 (2018.01); A61P 35/00 (2006.01); A61K 31/4035 (2006.01); A61K 31/454 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/025 (2013.01); C12Q 1/68 (2013.01); G01N 33/68 (2013.01); A61K 31/4035 (2013.01); A61K 31/454 (2013.01); A61P 35/00 (2018.01); C07K 14/47 (2013.01); C07K 19/00 (2013.01); C07K 2319/95 (2013.01); C12N 5/06 (2013.01); C12N 5/0635 (2013.01); C12N 5/0694 (2013.01); C12N 15/62 (2013.01); C12Q 1/6883 (2013.01); C12Q 1/6886 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/156 (2013.01);
Abstract

In one aspect, the invention features a method for identifying a drug-modulated polypeptide substrate of cereblon (CRBN). In another aspect, the invention features a method of identifying a polypeptide target of a modulator of CRBN. In yet another aspect, the invention provides methods of monitoring or characterizing the sensitivity of a subject to a modulator of CRBN.


Find Patent Forward Citations

Loading…